Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/<scp>TAF</scp>) as initial treatment in people with human immunodeficiency virus‐1 (<scp>HIV</scp>‐1): A systematic literature review of clinical and patient‐reported outcomes

Jade Ghosn, Lili Dai, Monica Gandhi et al.|HIV Medicine|2025

Cited by 1